Snoretox Ltd
In collaboration with RMIT University, Snoretox is developing the world’s first injectable solution to treat obstructive sleep apnoea and other conditions involving low muscle tone. Our game-changing technology is based on molecules of tetanus toxin, modified to ensure they work around the tetanus vaccine. Just as Botox uses tiny amounts of botulinum toxin to relax muscles, our prototype therapeutic uses minute amounts of safe modified tetanus toxin to achieve the opposite effect – muscle toning.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Snoretox Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- LN
Luke Norbury
Head of Preclinical Development · Research & Development
EmailPhone - TS
Tony Sasse
Md, Snoretox Ltd · Science
EmailPhone - KM
Kelly Makarounas-Kirchmann
Chairperson of the Board · General Business & Management
EmailPhone - PS
Peter Smooker
Chief Scientific Officer · Science
EmailPhone
Showing 4 of 5 verified contacts
Top roles at Snoretox Ltd
5 distinct titles indexed · top 5 shown.
- 1chairperson of the board
- 1chief scientific officer
- 1head of innovation
- 1head of preclinical development
- 1md, snoretox ltd
Sign up to unlock all 5 contacts at Snoretox Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Snoretox Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.